Colloids and Surfaces B Biointerfaces, Год журнала: 2024, Номер 247, С. 114407 - 114407
Опубликована: Ноя. 26, 2024
Язык: Английский
Colloids and Surfaces B Biointerfaces, Год журнала: 2024, Номер 247, С. 114407 - 114407
Опубликована: Ноя. 26, 2024
Язык: Английский
Pharmaceutics, Год журнала: 2025, Номер 17(2), С. 263 - 263
Опубликована: Фев. 17, 2025
Background: Thyroid cancer (TC) is the most prevalent endocrine malignancy, and categorized into well-differentiated aggressive anaplastic types. Novel therapeutic modalities are needed for TC. Nanomedicine a promising strategy development of precision medicine. In this context, we investigated use nanogels (NGs) to deliver agents with different physicochemical properties, specifically hydrophilic agent doxorubicin (DOX) hydrophobic compound curcumin (CUR), in TC cell lines. Methods: Nα-9-fluorenylmethoxycarbonyl-diphenylalanine (Fmoc-FF) peptide-based NGs loaded DOX CUR were formulated using solvent-switch method. DOX-loaded previously characterized. CUR-loaded characterized through rheology, scanning electron microscopy (SEM), dynamic light scattering (DLS), nanoparticle tracking analysis (NTA), Fourier transform infrared (FT-IR) spectroscopy. Confocal microscopy, q-RT-PCR, ATP lite assays performed evaluate uptake delivery DOX- on Results: exhibited mean diameter approximately 204.3 nm zeta potential -34.6 mV, indicative good stability. vitro release studies revealed sustained profile over 72 h. Functional analyses demonstrated that Fmoc-FF-loaded internalized They primarily localized cytoplasm rather than early endosomes, thereby ensuring intracellular Furthermore, Fmoc-FF reduced nuclear kinetics cells, suggesting reduction dose-limiting toxicity. Comparative similar internalization delayed uptake, highlighting efficacy delivering agents. Conclusions: Overall, data suggest represent diverse properties TC, enhancing their safety warranting further investigation.
Язык: Английский
Процитировано
2Inorganics, Год журнала: 2025, Номер 13(1), С. 21 - 21
Опубликована: Янв. 15, 2025
Herein, this work elucidates the synthesis of Pd-MoS2 catalyst for application in methanol-mediated overall water splitting. The scanning electron microscope (SEM) and transmission (TEM) pictures offer an exciting nanostructured shape Pd-MoS2, depicting a high surface area. Further, high-resolution TEM (HRTEM) confirm lattice plane (100), spacing (0.26 nm), hexagonal crystal structure Pd-MoS2. Moreover, high-angle annular dark-field (HAADF) images related color maps disclose Mo, S, Pd elements exhibits lower overpotentials 224.6 mV [methanol-mediated hydrogen evolution reaction (MM-HER)] at −10 mA cm−2 133 oxygen (MM-OER)] 10 cm−2. illustrates noteworthy stability 15.5 h MM-HER 18 MM-OER by chronopotentiometry test. Excitingly, Pd-MoS2∥Pd-MoS2 cell reveals small potential 1.581 V compared to MoS2∥MoS2 (1.648 V) In addition, combination brilliant durability over
Язык: Английский
Процитировано
1Journal of environmental chemical engineering, Год журнала: 2025, Номер unknown, С. 115998 - 115998
Опубликована: Фев. 1, 2025
Язык: Английский
Процитировано
1European Polymer Journal, Год журнала: 2024, Номер 218, С. 113347 - 113347
Опубликована: Июль 28, 2024
Язык: Английский
Процитировано
4Journal of Colloid and Interface Science, Год журнала: 2025, Номер 687, С. 742 - 755
Опубликована: Фев. 16, 2025
Язык: Английский
Процитировано
0Research Square (Research Square), Год журнала: 2025, Номер unknown
Опубликована: Март 31, 2025
Язык: Английский
Процитировано
0Next Nanotechnology, Год журнала: 2025, Номер 8, С. 100159 - 100159
Опубликована: Янв. 1, 2025
Язык: Английский
Процитировано
0Journal of Nanobiotechnology, Год журнала: 2025, Номер 23(1)
Опубликована: Апрель 22, 2025
Drug conjugates have emerged as a promising alternative delivery system designed to deliver an ultra-toxic payload directly the target cancer cells, maximizing therapeutic efficacy while minimizing toxicity. Among these, antibody-drug (ADCs) garnered significant attention from both academia and industry due their great potential for therapy. However, peptide-drug (PDCs) offer several advantages over ADCs, including more accessible industrial synthesis, versatile functionalization, high tissue penetration, rapid clearance with low immunotoxicity. These factors position PDCs up-and-coming drug candidates future Despite potential, face challenges such poor pharmacokinetic properties bioactivity, which hinder clinical development. How design meet needs is big challenge urgent resolve. In this review, we first carefully analyzed general consideration of successful PDC learning ADCs. Then, summarised basic functions each component construct, comprising peptides, linkers payloads. The peptides in were categorized into three types: tumor targeting cell penetrating peptide self-assembling peptide. We then these delivery, overcoming resistance, controlling release improving reduced non-specific To better understand druggability PDCs, discussed pharmacokinetics also briefly introduced current trials. Lastly, perspectives development oncology PDC. This review aimed provide useful information construction applications.
Язык: Английский
Процитировано
0Journal of Colloid and Interface Science, Год журнала: 2025, Номер 694, С. 137688 - 137688
Опубликована: Апрель 23, 2025
Язык: Английский
Процитировано
0Advanced Healthcare Materials, Год журнала: 2025, Номер unknown
Опубликована: Апрель 27, 2025
Abstract Molybdenum disulfide (MoS₂) nanomaterials have attracted significant interest in cancer diagnosis and therapy due to their unique physicochemical properties. Due its extensive surface area adaptable structure, MoS₂ may engage with pharmaceuticals biomolecules via covalent non‐covalent interactions. This versatility enhances the sensitivity of identifying specific biomarkers, colloidal stability, tumor‐targeting capabilities. In near‐infrared (NIR) spectrum, exhibits strong optical absorption efficient photothermal conversion, making it suitable for NIR‐driven phototherapy regulated medication release. Functionalized nanocomposites react differently tumor microenvironment, which improves treatment effectiveness by increasing drug accumulation at sites decreasing off‐target effects on healthy tissues. Recent developments MoS₂‐based detection are reviewed this study, particular attention paid uses therapy, photodynamic biosensing, bioimaging. Additionally, looks difficulties potential applications cancer.
Язык: Английский
Процитировано
0